Receptor tyrosine kinases as targets for anticancer drugs

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.8, Iss.1, 2002-01, pp. : 17-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases

Current Molecular Medicine, Vol. 6, Iss. 4, 2006-06 ,pp. : 409-421

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases and Inflammatory Signalling

Current Molecular Medicine, Vol. 9, Iss. 1, 2009-02 ,pp. : 69-85

Bentham Science Publishers

Access to resources Recommend Favorite

Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner

By Mitina Olga

Annals of Hematology, Vol. 86, Iss. 11, 2007-11 ,pp. : 777-785

Springer Publishing Company

Access to resources Recommend Favorite

Uncoupling of T-Cell Antigen Receptor and Downstream Protein Tyrosine Kinases in Common Variable Immunodeficiency

By Majolini M.B. D'Elios M.M. Boncristiano M. Galieni P. del Prete G. Telford J.L. Baldari C.T.

Clinical Immunology, Vol. 84, Iss. 1, 1997-07 ,pp. : 98-102

Academic Press

Access to resources Recommend Favorite

The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs

Current Molecular Medicine, Vol. 13, Iss. 7, 2013-08 ,pp. : 1089-1097

Bentham Science Publishers

Access to resources Recommend Favorite